Comparing Efficacy of Intravenous Dexmedetomidine and Lidocaine on Postoperative Analgesia in Patients Undergoing Fracture Hip Surgery

Launched by ASSIUT UNIVERSITY · Mar 4, 2025

Keywords

ClinConnect Summary

This clinical trial is investigating two medications, intravenous dexmedetomidine and lidocaine, to see which one is more effective at managing pain after hip fracture surgery. Hip fractures are common and can lead to significant pain and complications, especially in older adults. The goal of the study is to find out how well these medications help reduce pain and the need for stronger painkillers after surgery, as well as to understand any side effects they may cause.

To participate in the trial, individuals must be over 18 years old and generally healthy (classified as American Society of Anesthesiologists class I or II). Those with a high body mass index, allergies to the medications, or ongoing issues with pain management won’t be eligible. Participants will receive either dexmedetomidine or lidocaine during their surgery, and researchers will monitor their pain levels, use of pain medications, and any side effects afterward. This study aims to improve pain management strategies for hip fracture surgeries, ultimately enhancing recovery for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age more than 18 years old.
• • patients with both sex
• • patients who are American society of Anesthesiologists class I or II
• Exclusion Criteria:
• • refusal.
• • body mass index (BMI) ≥40 kg/m2.
• • History of hypersensitivity to the drugs being evaluated
• • Inability to comprehend postoperatively the pain assessment scale/neuropsychiatric disorders.
• • chronic use of opioids and opioid addiction